NFSG
GBT

Newbridge Financial Services Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Newbridge Financial Services Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-44
Closed -$3K – 1534
2022
Q3 		$3K Hold
44
– – ﹤0.01% 1170
2022
Q2 		$1K Hold
44
– – ﹤0.01% 1336
2022
Q1 		$2K Hold
44
– – ﹤0.01% 1349
2021
Q4 		$1K Hold
44
– – ﹤0.01% 1392
2021
Q3 		$1K Hold
44
– – ﹤0.01% 1360
2021
Q2 		$2K Hold
44
– – ﹤0.01% 1316
2021
Q1 		$2K Buy
+44
New +$2.02K ﹤0.01% 1220

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Newbridge Financial Services Group's GBT Position: Q4 2022 in Review

Newbridge Financial Services Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 44 shares — an estimated $3K sold.

Newbridge Financial Services Group first reported a position in GBT in Q1 2021 and held it in 7 quarters. The position peaked at $3K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Newbridge Financial Services Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 44 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3K.
  • Newbridge Financial Services Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2021 and held it in 7 quarters.
  • Newbridge Financial Services Group's Global Blood Therapeutics, Inc. position peaked at $3K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Newbridge Financial Services Group's 13F filing for Q4 2022, filed 17 Jan 2023.